Tumor-intrinsic and immune modulatory roles of receptor-interacting protein kinases

Area of Science:

• Molecular Biology
• Immunology
• Oncology

Background:

• Receptor-interacting protein kinase 1 (RIPK1) and RIPK3 are crucial signaling adaptors involved in regulating programmed cell death and inflammatory responses.
• Tumors can evade or exploit RIPK-mediated cell death pathways, indicating their significant role in cancer development and progression.
• Dysregulation of RIPK signaling in the tumor microenvironment can either promote tumor growth or enhance anti-tumor immunity.

Purpose of the Study:

• To review recent advancements in understanding the regulation of RIPK activity within tumors and immune cells.
• To explore the coordinated roles of RIPK signaling in tumorigenesis and anti-tumor immunity.
• To highlight the context-dependent functions of RIPKs in cancer.

Main Methods:

• Literature review of recent research on RIPK signaling in cancer.
• Analysis of studies investigating RIPK regulation in tumor cells and immune effectors.
• Synthesis of findings on the interplay between RIPKs, cell death, inflammation, and the tumor microenvironment.

Main Results:

• RIPK activity is dynamically regulated in both cancer cells and the tumor microenvironment.
• RIPK-dependent cell death can promote durable anti-tumor immunity, but RIPKs can also drive inflammation and tumor progression.
• The effects of RIPKs on tumor growth are contingent on the specific cellular context and interactions within the tumor microenvironment.

Conclusions:

• RIPK signaling plays multifaceted and context-dependent roles in cancer, influencing cell death, inflammation, and immune responses.
• Targeting RIPK pathways presents potential therapeutic strategies for cancer, but requires careful consideration of their dual roles.
• Further research is needed to fully elucidate the complex interplay of RIPKs in tumorigenesis and to optimize their therapeutic targeting.